Consolidation chemotherapy following concurrent chemoradiation therapy for locally advanced inoperable non-small cell lung cancer
10.3760/cma.j.issn.1673-422X.2011.10.016
- VernacularTitle:局部晚期非小细胞肺癌同步放化疗后巩固化疗
- Author:
Xujuan YU
;
Zhijian CHEN
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small-cell lung;
Radiotherapy,adjuvant;
Drug therapy,combination;
Chemotherapy,adjuvant
- From:
Journal of International Oncology
2011;38(10):767-770
- CountryChina
- Language:Chinese
-
Abstract:
Concurrent chemoradiation therapy is currently a recommended treatment approach for locally advanced inoperable stage ⅢA and stage ⅢB non-small cell lung cancer (NSCLC).There is no consensus on the optimal treatment regimen.It is one of these options for the consolidation chemotherapy following concurrent chemoradiation therapy.To date,there is no sufficient evidence indicating that consolidation chemotherapy following concurrent chemoradiation therapy further improves survival rates.The benefit remains to be confirmed by more clinical test.
